Preoperative risk factors | Patients without delirium (n = 443) | Patients with delirium (n = 488) | p-value |
---|---|---|---|
Demographic characteristics | Â | Â | Â |
 Age in years, (mean ± SD) | 52.94 ± 12.84 | 65.17 ± 9.26 |  < 0.001* |
 Male gender (%) | 306 (70.8) | 314 (64.3) | 0.036* |
 Married patients (%) | 388 (89.8) | 478 (98) |  < 0.001* |
 Having family support (%) | 413 (95.6) | 465 (95.3) | 0.819 |
 Body mass index, (mean ± SD) | 26.17 ± 4.57 | 26.98 ± 11.60 | 0.175 |
 Education level, diploma and higher (%) | 339 (78.5) | 182 (37.3) |  < 0.001* |
 Smoker, yes (%) | 73 (16.9) | 236 (48.4) |  < 0.001* |
 Addiction, yes (%) | 17 (3.9) | 121 (24.8) |  < 0.001* |
Clinical characteristics | Â | Â | Â |
 Charlson Comorbidity Index (CCI) score, ≥ 4 (%) | 137 (31.7) | 361 (74) |  < 0.001* |
 APACHE II, ≤ 10 (%) | 60 (13.9) | 364 (74.6) |  < 0.001* |
 EURO score, ≥ 3 (%) | 123 (28.5) | 355 (72.7) |  < 0.001* |
 Metabolic syndrome, yes (%) | 1 (0.2) | 5 (1) | 0.136 |
 Ejection fraction (EF), ≤ 50% (%) | 199 (46.1) | 344 (70.5) |  < 0.001* |
 Carotid status, stenosis < 50% with occlusion (%) | 319 (73.8) | 210 (43) |  < 0.001* |
 Nutrition status, malnourished (%) | 1 (0.2) | 1 (0.2) | 0.931 |
 Angiography history, ≥ 8 (%) | 231 (53.5) | 200 (41) |  < 0.001* |
 Parkinson’s disease history, yes (%) | 1 (0.2) | 7 (1.4) | 0.073 |
 Sleep disorder history, yes (%) | 60 (13.9) | 362 (74.2) |  < 0.001* |
 Psychiatric disorder history, yes (%) | 2 (0.5) | 31 (6.4) |  < 0.001* |
 Speech problem history, yes (%) | 1 (0.2) | 7 (1.4) | 0.073 |
 Visual impairment history, yes (%) | 40 (9.3) | 192 (39.3) |  < 0.001* |
 Hearing impairment history, yes (%) | 11 (2.5) | 133 (27.3) |  < 0.001* |
 Admission history, yes (%) | 260 (60.2) | 445 (91.2) |  < 0.001* |
 Coronary artery disease (CAD), yes (%) | 292 (67.6) | 315 (64.5) | 0.331 |
 Valve impairments, yes (%) | 140 (32.4) | 173 (35.5) | 0.331 |
Laboratory data | Â | Â | Â |
 Hematocrit (Hct) levels, median (IQR) | 43.3 (39.05–64.4) | 40.5 (36.8–44.20) |  < 0.001* |
 Creatinine (Cr) levels (mg/dL), median (IQR) | 1.1 (0.9–1.2) | 1.2 (1–1.3) |  < 0.001* |
Medication data | Â | Â | Â |
 Atorvastatin history, yes (%) | 384 (88.9) | 465 (95.3) |  < 0.001* |
 Warfarin history, yes (%) | 3 (0.7) | 11 (2.3) | 0.062 |
 Benzodiazepines history, yes (%) | 59 (13.7) | 353 (72.3) |  < 0.001* |
 Number of medications, ≥ 4 (%) | 234 (54.2) | 374 (76.6) |  < 0.001* |